The media wont bother to write up this Chemeq news. As you can...

The media wont bother to write up this Chemeq news. As you can see from the key news below lodged with the ASX late yesterday, is a notice showing that CMQ directors all added to their already substantial holdings No one should lose site of the fact that since floating on the ASX, they have barely sold a share even when they had a high of $8. No one would have blamed them if they had of sold a small parcel to buy a holiday house, or help the grandchildren out, but they didn't. This now leads me to refer back to one of the first "cut the tall poppy down" articles which helped crucify Chemeq's shareprice back on 30 July 07 written by Geoff Elliott of The Australian, who writes Criterion. The key first paragraph read .......

There's something strangely redolent of the dotcom era with Chemeq, a Perth-based animal biotech company that promises to revolutionise feed for the poultry and pig industry".

From what I remember about the dotcom era most of the companies that led the charge to consume investor dollars, never built anything tangible (like a world first manufacturing plant) and more importantly directors sold shares and options (that cost them squat) for fortunes before the bubble burst. When my wife saw this article, even she remembered the unsavoury dotcom era and questioned my logic of "what are we doing in a company like this". Fortunately I resisted the pressure to sell any of our Chemeq shares, because I had done due diligence on this company and was very reassured by knowing the history of director shareholdings. I not only liked the potential of the company, but the very fact that the directors financially supported the company to the hilt was extremely reassuring. What I now wonder about, is how many mum and dad investors have murdered their investment in this company because of articles like Criterion, and the ongoing vendetta W.A news writer Michael Weir seems to have against Dr Melrose.

W.R.
T.U

============================================
Change of Director’s Interest Notice

Name of entity – CHEMEQ LIMITED

ABN – 77 009 135 264

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the

director for the purposes of section 205G of t000he Corporations Act.

Name of Director RUSSELL CHILTON BARNETT

Date of last notice 05/03/2004

Part 1 - Change of director’s relevant interests in securities



Direct or indirect interest DIRECT

Nature of indirect interest

(including registered holder)



Date of change 06/10/2004

No. of securities held prior to change ORDINARY SHARES = 2,392,214

30/06/05 OPTIONS = NIL

Class SEE ABOVE

Number acquired ORDINARY SHARES = 1,082

30/06/05 OPTIONS = 1,082

Number disposed -

Value/Consideration

$2,597

No. of securities held after change ORDINARY SHARES = 2,393,296

30/06/05 OPTIONS = 1,082

=====================================================

Change of Director’s Interest Notice



Name of entity – CHEMEQ LIMITED

ABN – 77 009 135 264

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the

director for the purposes of section 205G of the Corporations Act.

Name of Director GRAEME ALEXANDER MAJOR

Date of last notice 14/09/2004

Part 1 - Change of director’s relevant interests in securities



Direct or indirect interest DIRECT & INDIRECT

Nature of indirect interest

(including registered holder)



SECURITY FOR LOAN, REGISTERED

HOLDER IS MR CRAIG RUSSELL

MANNING

Date of change 06/10/2004

No. of securities held prior to change ORDINARY SHARES = 5,712,020

30/06/05 OPTIONS = NIL

Class SEE ABOVE

Number acquired ORDINARY SHARES = 90,745

30/06/05 OPTIONS = 90,745

Number disposed NIL

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

$217,788

No. of securities held after change ORDINARY SHARES = 5,802,765

30/06/05 OPTIONS = 90,745

=====================================================

Change of Director’s Interest Notice



Name of entity – CHEMEQ LIMITED

ABN – 77 009 135 264

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the

director for the purposes of section 205G of the Corporations Act.

Name of Director GRAHAM JOHN HAMILTON MELROSE

Date of last notice 05/03/2004

Part 1 - Change of director’s relevant interests in securities



Direct or indirect interest DIRECT AND INDIRECT

Nature of indirect interest

(including registered holder)



* MELROSE GHJ & OM PTY LTD

* ANZ NOMINEES LIMITED (SECURITY

FOR LOAN)

Date of change 12/10/2004

No. of securities held prior to change ORDINARY SHARES = 23,717,221

30/06/05 OPTIONS = NIL

Class SEE ABOVE

Number acquired ORDINARY SHARES = 2,540,384

30/06/05 OPTIONS = 2,540,384

Number disposed NIL

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

$6,096,922

No. of securities held after change ORDINARY SHARES = 26,257,605

30/06/05 OPTIONS = 2,540,384



SUB-UNDERWRITER TO COMPANY

RIGHTS ISSUE (AS DESCRIBED IN

PROSPECTUS)

=====================================================



Change of Director’s Interest Notice



Name of entity – CHEMEQ LIMITED

ABN – 77 009 135 264

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the

director for the purposes of section 205G of the Corporations Act.

Name of Director RAYMOND VICTOR STEFFANONI

Date of last notice 05/03/2004

Part 1 - Change of director’s relevant interests in securities



Direct or indirect interest DIRECT AND INDIRECT

Nature of indirect interest

(including registered holder)



STEFFANONI SUPERANNUATION

FUND

Date of change 06/10/2004

No. of securities held prior to change ORDINARY SHARES = 163,649

30/06/05 OPTIONS = NIL

Class SEE ABOVE

Number acquired ORDINARY SHARES = 9,408

30/06/05 OPTIONS = NIL

Number disposed NIL

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

$22,580

No. of securities held after change ORDINARY SHARES = 173,057

30/06/05 OPTIONS = 9,408

Appendix 3Y